
Botanix Pharmaceuticals has seen a sharp volume spike after a major share price decline, hinting at possible bottoming. While Sofdra sales are growing and funding has improved liquidity, the stock remains in a downtrend, with any recovery dependent on stronger fundamentals and a break above key resistance.

Qantas (ASX: QAN) has pulled back sharply in 2026, but the decline is largely driven by cyclical pressures rather than a broken business. The key trigger has been a surge in jet fuel costs, which have more than doubled in recent months.

Liontown Resources has rallied on stronger lithium prices, improving production at Kathleen Valley, and a healthier balance sheet after reducing debt. Rising EV and battery demand plus new offtake deals have lifted sentiment. The stock is now approaching key resistance around A$2.20, where the next breakout or pullback will likely be decided.

Invictus Energy is an early-stage oil and gas explorer in Zimbabwe with large but unproven resource potential. With no revenue and heavy funding needs, the stock offers significant upside if discoveries succeed, but remains a high-risk, news-driven investment.

Recent tariff changes and trade frictions have disrupted that advantage and slowed growth. However, CETTIRE’s flexible, low-cost structure suggests its core model remains intact, leaving the company with meaningful long-term profit potential despite the current uncertainty around customer growth and demand.

Rising fuel costs are speeding up EV adoption, with global sales surpassing 20 million in 2025 and now over 20% of new car sales. This directly boosts lithium demand, positioning ASX lithium stocks to benefit from both EV growth and pricing cycles.